Appili Lands $3.3M, Starts Next Round

Halifax-based drug discovery company Appili Therapeutics Inc. has announced $3.3 million in funding and outlined a strategy based on “hitting singles and home runs”.
Standing in his recently opened lab, Founder and CEO Kevin Sullivan said the company is now working on a drug with a limited market that should be on the market in a few years, and a larger, riskier project to combat